Vanguard Group »

Xenon Pharmaceuticals shares owned by Vanguard Group

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 324k 46.06
2023-09-30 $9.1M 267k 34.16
2023-06-30 $10M 261k 38.50
2023-03-31 $8.9M 249k 35.79
2022-12-31 $7.6M 192k 39.43
2022-06-30 $5.6M 184k 30.42
2022-03-31 $5.0M 164k 30.57
2021-09-30 $1.6M 107k 15.28
2021-06-30 $1.9M 103k 18.56
2021-03-31 $1.9M 107k 17.86
2020-12-31 $1.5M 98k 15.35
2020-09-30 $1.1M 95k 11.07
2020-06-30 $1.2M 95k 12.58